ExLibris header image
SFX Logo
Title: Time Resolved Native Ion-Mobility Mass Spectrometry to Monitor Dynamics of IgG4 Fab Arm Exchange and “Bispecific” Monoclonal Antibody Formation
Source:

Analytical Chemistry [0003-2700] François Debaene, Elsa yr:2013


Collapse list of basic services Basic
Full text
Full text available via American Chemical Society Journals
GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. "Biosimilars." Pharmazie in unserer Zeit 41.6 (2012): 437-437. Link to Full Text for this item Link to SFX for this item
2. Arndt, Michael P. "Characterization of a novel single-chain bispecific antibody for retargeting of T cells to tumor cells via the TCR co-receptor CD8." PLoS ONE 9.4 (2014). Link to Full Text for this item Link to SFX for this item
3. Z, Z. "High Level Secretion of a Humanized Bispecific Diabody from Escherichia coli." Bio/technology 14.2 (1996): 192-6. Link to SFX for this item
4. Genetic engineering & biotechnology news 31.10 (2011): 30-. Link to SFX for this item
5. Aringer, M. Zeitschrift für Rheumatologie 72.9 (2013): 873-877. Link to SFX for this item
6. Kamada, H. "Generation and characterization of a bispecific diabody targeting both EPH receptor A10 and CD3." Biochemical and biophysical research communications 456.4 (2015): 908-912. Link to SFX for this item
7. Malozowski, S. "Biosimilars." Arquivos brasileiros de endocrinologia e metabologia 55.8 (2011): 669-670. Link to SFX for this item
8. Patel, Kedar G. "Escherichia coli-based production of a tumor idiotype antibody fragment - tetanus toxin fragment C fusion protein vaccine for B cell lymphoma." Protein expression and purification 75.1 (2011): 15-20. Link to SFX for this item
9. Vaquero, C. "A carcinoembryonic antigen-specific diabody produced in tobacco." The FASEB journal 16.1 (2002): 408-10. Link to SFX for this item
10. Gray, G L L. "Periplasmic production of correctly processed human growth hormone in Escherichia coli: natural and bacterial signal sequences are interchangeable." Gene 39.2-3 (1985): 247-254. Link to Full Text for this item Link to SFX for this item
11. Behr, M.A. A. "Comparative Genomics of BCG Vaccines by Whole-Genome DNA Microarray." Science 284.5419 (1999): 1520-1523. Link to SFX for this item
12. Taylor, P. Rheumatology. 56.s2: 9-9. Link to SFX for this item
13. Tsiftsoglou, Asterios S. "Development and Regulation of Biosimilars: Current Status and Future Challenges." BioDrugs 27.3 (2013): 203-211. Link to SFX for this item
14. Prugnaud, J. Biosimilars. 2013. Link to SFX for this item
15. Gámez-Belmonte, R. "Biosimilars: Concepts and controversies." Pharmacological research. 133: 251-264. Link to SFX for this item
16. Rathore, Anurag S. S. "Biosimilars in India." Journal of proteomics 127.Pt A (2015): 71-72. Link to SFX for this item
17. Deng, Lizhou u. "Biological production of adipic acid from renewable substrates: Current and future methods." Biochemical engineering journal 105.Part A: 16-26. Link to SFX for this item
18. Sun, L. Laura. "Pre-Clinical Characterization of T Cell-Dependent Bispecific Antibody Anti-CD79b/CD3 As a Potential Therapy for B Cell Malignancies." Blood 2014. Link to SFX for this item
19. Patel, Palak K K. "Biologics and biosimilars." The Journal of dermatological treatment 26.4 (2015): 1-4. Link to SFX for this item
20. Graninger, W. Rheuma plus 13.1 (2014): 4-6. Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced